News

12 December 2009
Company officials were joined at the ribbon cutting ceremony by Massachusetts Lieutenant Governor Timothy P Murray, Massachusetts Life Sciences Center President and CEO Dr. Susan Windham-Bannister, Deputy Director and General Counsel to the Massachusetts Department of Business and Technology George Ramirez representing the Massachusetts Office of International Trade & Investment, MassBio Economic Development Director Peter Abair, and other state and local officials.  
10 December 2009
The virtual one, of course, but still.... Out of over 3000 virtual skippers at the helm of their Imoca60 virtual boats racing across the virtual Atlantic in the same wind conditions as the real (courageous) skippers, the CYTOO boats reached Costa Rica first in the "confirmed entrepreneur" class.  
02 December 2009
French Cell Chip Maker CYTOO Raises $4.7M, Opens US Shop December 01, 2009  By Justin Petrone Looking to tap into demand for high-throughput, cell-based assays from North American customers, French startup CYTOO recently raised $4.7 million to help it establish a US subsidiary near Boston. Founded last year in Grenoble, CYTOO currently sells CYTOOchips, which each comprises a 2 cm x 2 cm glass surface containing 144 micropattern arrays that provide 20,000 micropatterns per chip.  CYTOOplates, glass-bottom microplates in 96- or 384-well format, where each well holds an array...
19 November 2009
Grenoble, France, and Framingham, MA, 17 November, 2009 – CYTOO SA, a provider of innovative enabling technologies and products for high content cell analysis, announces today the opening of its wholly-owned U.S.-based subsidiary, CYTOO Inc., naming William T. Sharp president and CEO. Sharp also becomes a member of the Board of parent company Cytoo SA. Sharp, who brings 30 years’ life science tools, diagnostics, and clinical product market experience to CYTOO, will have worldwide responsibilities for sales and marketing. He will also be charged with setting up co-distribution and...
28 September 2009
Grenoble, France, 28 September, 2009 – CYTOO SA, a provider of innovative enabling technologies and products for high content cell analysis, today announced the closing of a second funding round of USD 4.7M (EUR 3.2M). New investor, Auriga Partners, led the round. An existing investor Jacques Lewiner, co-founder and president of the supervisory board at CYTOO, also took part. CYTOO will use the financing to grow its business internationally, expand the team and further its research and development in an area that is attracting increasing scientific and industrial interest. “We are very...
24 September 2009
CYTOO has Marketing and Sales positions open in the USA Check out our Careers page
09 September 2009
The CYTOOchamber™ is a 35mm footprint device specially designed and manufactured for our 2x2cm² square CYTOOchip™ format which enables you to do high resolution timelapse microscopy. The CYTOOchamber uses a patented magnetic system (from Live Cell Instrument) for easy assembly. It is recommended for weak fluorescence signal observation. The CYTOOchamber has the same footprint as standard 35mm culture dishes and therefore will fit into all 35mm microscope stage adaptors.  
07 September 2009
CYTOO’s breakthrough adhesive micropattern technology for cell assay variability reduction generates significant interest from cell biologists CYTOO SA, a provider of innovative enabling technologies and products for high content cell analysis, premiered what it believes is the world's first and most comprehensive commercially available portfolio of cell adhesive micropattern products to the cell biology research community at the EMBO Meeting last week in Amsterdam. The 2x2 sq.cm micropatterned glass substrate CYTOOchip™ is the only commercially available cell analysis tool based on a...
27 April 2009
CYTOO Cell Architects has entered into an exclusive worldwide license agreement for the adhesive micropattern patent portfolio from the Curie Institute and the CNRS. The company has also solidified its freedom to operate commercially with signed patent license agreements with the CEA (Life Sciences Division) and Harvard University. Following execution of these licenses, CYTOO immediately launched the CYTOOchips as its first product on the research market.
04 December 2008
2008-12-05 Cytoo raises €1 Million in Seed investment. This first round will finance premises in MINATEC center and the launch of Cytoo's first product: the CytooChips. Investors include CEA Valorisation, Rhône-Alpes-Creation and Expansinvest as well as private investors. Read the press release 

Pages